🇰🇷 Pombiliti in South Korea

Pombiliti (CIPAGLUCOSIDASE ALFA) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Pombiliti in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in South Korea

Frequently asked questions

Is Pombiliti approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Pombiliti in South Korea?

Amicus Therapeutics Europe Limited is the originator. The local marketing authorisation holder may differ — check the official source linked above.